Terms: = Prostate cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Diagnosis
64 results:
1. Pretest Video Education Versus Genetic Counseling for Patients With prostate cancer: ProGen, A Multisite Randomized Controlled Trial.
Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
[TBL] [Abstract] [Full Text] [Related]
2. Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced prostate cancer.
Neeb A; Figueiredo I; Gurel B; Nava Rodrigues D; Rekowski J; Riisnaes R; Ferreira A; Miranda S; Crespo M; Westaby D; de Los Dolores Fenor de La Maza M; Guo C; Carmichael J; Grochot R; Tunariu N; Cato ACB; Plymate SR; de Bono JS; Sharp A
Lab Invest; 2023 Nov; 103(11):100245. PubMed ID: 37652207
[TBL] [Abstract] [Full Text] [Related]
3. Deregulation of miR-10b and miR-21 Correlate with cancer Stem Cells Expansion through the Apoptotic Pathway in prostate cancer.
Shukla KK; Choudhary GR; Sankanagoudar S; Misra S; Vishnoi JR; Pareek P; Pilla KK; Pandey SN; Sharma P
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2105-2119. PubMed ID: 37378942
[TBL] [Abstract] [Full Text] [Related]
4. [Solitary fibrous tumor of the prostate: case report].
Ahnou D; Belkacem-Nacer A; Boubrit M
Pan Afr Med J; 2021; 39():285. PubMed ID: 34754362
[TBL] [Abstract] [Full Text] [Related]
5. Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance.
Campbell KJ; Leung HY
Cancer Lett; 2021 Nov; 520():213-221. PubMed ID: 34343635
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in prostate cancer diagnosis.
Zhang W; Dong Y; Sartor O; Zhang K
Cancer Prev Res (Phila); 2021 Jul; 14(7):741-752. PubMed ID: 33866309
[TBL] [Abstract] [Full Text] [Related]
7. Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis.
Matulewicz RS; Basak R; Zambrano I; Dearing BA; Schatz D; El Shahawy O; Sherman S; Bjurlin MA
J Urol; 2021 May; 205(5):1444-1451. PubMed ID: 33347778
[TBL] [Abstract] [Full Text] [Related]
8. Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins.
Noé V; Aubets E; Félix AJ; Ciudad CJ
Biochem Pharmacol; 2021 Jul; 189():114371. PubMed ID: 33338475
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis.
Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733
[TBL] [Abstract] [Full Text] [Related]
11. Circulating mRNA signature as a marker for high-risk prostate cancer.
Souza MF; Kuasne H; Barros-Filho MC; Cilião HL; Marchi FA; Fuganti PE; Rogatto SR; Cólus IMS
Carcinogenesis; 2020 Apr; 41(2):139-145. PubMed ID: 31305891
[TBL] [Abstract] [Full Text] [Related]
12. National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database.
Kang HW; Yun SJ; Chung JI; Choi H; Kim JH; Yu HS; Ha YS; Cho IC; Kim HJ; Chung HC; Koh JS; Kim WJ; Park JH; Lee JY; Kim SY
BMC Health Serv Res; 2019 Jun; 19(1):408. PubMed ID: 31234845
[TBL] [Abstract] [Full Text] [Related]
13. prostate cancer aggressiveness and age: Impact of p53, bcl-2 and microvessel density.
Calvocoressi L; Uchio E; Ko J; Radhakrishnan K; Aslan M; Concato J
J Investig Med; 2018 Dec; 66(8):1142-1146. PubMed ID: 30297390
[TBL] [Abstract] [Full Text] [Related]
14. Negative Multiparametric Magnetic Resonance Imaging for prostate cancer: What's Next?
Panebianco V; Barchetti G; Simone G; Del Monte M; Ciardi A; Grompone MD; Campa R; Indino EL; Barchetti F; Sciarra A; Leonardo C; Gallucci M; Catalano C
Eur Urol; 2018 Jul; 74(1):48-54. PubMed ID: 29566957
[TBL] [Abstract] [Full Text] [Related]
15. A rare case of malignant solitary fibrous tumor in prostate with review of the literature.
Ronchi A; La Mantia E; Gigantino V; Perdonà S; De Sio M; Facchini G; Franco R; De Chiara A
Diagn Pathol; 2017 Jul; 12(1):50. PubMed ID: 28687087
[TBL] [Abstract] [Full Text] [Related]
16. bcl2 genotypes and prostate cancer survival.
Renner W; Langsenlehner U; Krenn-Pilko S; Eder P; Langsenlehner T
Strahlenther Onkol; 2017 Jun; 193(6):466-471. PubMed ID: 28396899
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathologic features of solitary fibrous tumor in urogenital system].
Ruan HJ; Huang AH; Cheng S; Fu GX
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):248-51. PubMed ID: 27033388
[TBL] [Abstract] [Full Text] [Related]
18. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With cancer.
Ramsey SD; Bansal A; Fedorenko CR; Blough DK; Overstreet KA; Shankaran V; Newcomb P
J Clin Oncol; 2016 Mar; 34(9):980-6. PubMed ID: 26811521
[TBL] [Abstract] [Full Text] [Related]
19. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
[TBL] [Abstract] [Full Text] [Related]
20. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
Muller J; Grosclaude P; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bara S; Colonna M; Troussard X; Bouvier V; Trétarre B; Velten M; Jégu J
BJU Int; 2016 Jul; 118(1):53-9. PubMed ID: 26469096
[TBL] [Abstract] [Full Text] [Related]
[Next]
